Kalaris Therapeutics (KLRS) Interest & Investment Income (2019 - 2024)
Kalaris Therapeutics (KLRS) recorded Interest & Investment Income of $1.39 million in Q4 2024, up 1.0% from $1.37 million a year earlier but down 7.2% from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Interest & Investment Income (2019 - 2024) Analysis & Trends
For FY2024, Kalaris Therapeutics reported Interest & Investment Income of $5.49 million, down 4.3% from FY2023.
- Annual Interest & Investment Income has a five-year compound annual growth rate of 21.6% (FY2019 to FY2024).
- Across earlier years, Interest & Investment Income came in at $5.73 million in FY2023 (+205.7%), $1.88 million in FY2022 (+42.7%), $1.32 million in FY2021 (-1.1%) and $1.33 million in FY2020 (-35.6%).
- Quarterly Interest & Investment Income has ranged from $82,000 in Q4 2021 to $1.52 million in Q3 2023 over the past five years.
- On a year-over-year basis, Interest & Investment Income rose in five of the last eight quarters, with growth averaging 224.3%.
- Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 995.1% in Q4 2022, against a decline of 86.2% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.49 million (Q3 2024), $1.36 million (Q2 2024) and $1.25 million (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Kalaris Therapeutics | 64.27 Mn | 64.27 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 1.39 Mn |
| Sep 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 1.36 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 1.52 Mn |
| Mar 31, 2023 | 1.33 Mn |
| Dec 31, 2022 | 898,000.00 |
| Sep 30, 2022 | 668,000.00 |
| Jun 30, 2022 | 162,000.00 |
| Mar 31, 2022 | 148,000.00 |
| Dec 31, 2021 | 82,000.00 |
| Sep 30, 2021 | 253,000.00 |
| Jun 30, 2021 | 475,000.00 |
| Mar 31, 2021 | 505,000.00 |
| Dec 31, 2020 | 595,000.00 |
| Sep 30, 2020 | 112,000.00 |
| Jun 30, 2020 | 166,000.00 |
| Mar 31, 2020 | 457,000.00 |
API Access
Kalaris Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();